181 related articles for article (PubMed ID: 29522714)
1. SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion.
Chen Z; Raghoonundun C; Chen W; Zhang Y; Tang W; Fan X; Shi X
Biochem Biophys Res Commun; 2018 Apr; 498(3):579-585. PubMed ID: 29522714
[TBL] [Abstract][Full Text] [Related]
2. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
[TBL] [Abstract][Full Text] [Related]
3. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
4. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
5. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of TYRO3 Receptor Tyrosine Kinase Expression in Gastric Cancer.
Uejima C; Morimoto M; Yamamoto M; Hara K; Miyauchi W; Sugezawa K; Tada Y; Tanio A; Kihara K; Matsunaga T; Tokuyasu N; Sakamoto T; Honjo S; Umekita Y; Fujiwara Y
Anticancer Res; 2020 Oct; 40(10):5593-5600. PubMed ID: 32988883
[TBL] [Abstract][Full Text] [Related]
7. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
Su Z; Zhao J; Rong Z; Geng W; Wang Z
Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
[TBL] [Abstract][Full Text] [Related]
8. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
11. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
13. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
14. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
15. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
[TBL] [Abstract][Full Text] [Related]
19. miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2.
Shi J; Gong L; Chen L; Luo J; Song G; Xu J; Lv Z; Tao H; Xia Y; Ye Z
Anat Rec (Hoboken); 2019 Jun; 302(6):931-940. PubMed ID: 30737902
[TBL] [Abstract][Full Text] [Related]
20. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.
Cao C; Sun D; Zhang L; Song L
Oncotarget; 2016 Nov; 7(48):79956-79963. PubMed ID: 27835599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
